Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
NeoGenomics Inc ha un obiettivo di prezzo di consenso pari a $15.21, stabilito in base alle ultime valutazioni degli analisti di 17. Le ultime 3 valutazioni degli analisti sono state rilasciate da TD Cowen, Stephens & Co. y Needham il septiembre 12, 2025, septiembre 2, 2025 y agosto 29, 2025. Con un obiettivo di prezzo medio di $12.33 tra le TD Cowen, Stephens & Co. y Needham, c'è un implicito 33.33% upside per NeoGenomics Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
TD Cowen
Stephens & Co.
Needham
Piper Sandler
Morgan Stanley
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para NeoGenomics
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
09/12/2025 | 29.73% | TD Cowen | $10 → $12 | Maintains | Buy | |||
09/02/2025 | 18.92% | Stephens & Co. | $6.5 → $11 | Maintains | Overweight | |||
08/29/2025 | 51.35% | Needham | $8 → $14 | Maintains | Buy | |||
08/04/2025 | 18.92% | Piper Sandler | $12 → $11 | Maintains | Overweight | |||
07/30/2025 | -13.51% | Morgan Stanley | $10 → $8 | Maintains | Equal-Weight | |||
07/29/2025 | -13.51% | Needham | $8.5 → $8 | Maintains | Buy | |||
07/29/2025 | — | William Blair | — | — | Downgrade | Outperform → Market Perform | ||
05/06/2025 | 29.73% | Piper Sandler | $18 → $12 | Maintains | Overweight | |||
05/01/2025 | 8.11% | Morgan Stanley | $17 → $10 | Maintains | Equal-Weight | |||
04/30/2025 | 8.11% | Goldman Sachs | $15 → $10 | Maintains | Buy | |||
04/30/2025 | -2.7% | Leerink Partners | $25 → $9 | Downgrade | Outperform → Market Perform | |||
04/29/2025 | -8.11% | Needham | $18 → $8.5 | Maintains | Buy | |||
04/17/2025 | 62.16% | Goldman Sachs | $17 → $15 | Maintains | Buy | |||
02/26/2025 | 94.59% | Piper Sandler | $21 → $18 | Maintains | Overweight | |||
02/19/2025 | 72.97% | B of A Securities | $19 → $16 | Maintains | Neutral | |||
02/19/2025 | 94.59% | Needham | $19 → $18 | Maintains | Buy | |||
01/28/2025 | 94.59% | Goldman Sachs | $20 → $18 | Maintains | Buy | |||
01/16/2025 | — | Benchmark | — | Reiterates | Hold → Hold | |||
01/15/2025 | 105.41% | Needham | $19 → $19 | Reiterates | Buy → Buy | |||
01/13/2025 | — | Benchmark | — | Downgrade | Buy → Hold | |||
01/10/2025 | 105.41% | Needham | $19 → $19 | Reiterates | Buy → Buy | |||
12/13/2024 | 105.41% | B of A Securities | $18 → $19 | Maintains | Neutral | |||
12/10/2024 | 137.84% | Jefferies | → $22 | Initiates | → Buy | |||
11/06/2024 | 105.41% | Needham | $19 → $19 | Reiterates | Buy → Buy | |||
09/25/2024 | 105.41% | Needham | $19 → $19 | Reiterates | Buy → Buy | |||
09/24/2024 | 94.59% | Benchmark | $18 → $18 | Reiterates | Buy → Buy | |||
07/30/2024 | 105.41% | Stephens & Co. | $19 → $19 | Reiterates | Overweight → Overweight | |||
07/30/2024 | 94.59% | Benchmark | $18 → $18 | Reiterates | Buy → Buy | |||
07/30/2024 | 105.41% | Needham | $19 → $19 | Reiterates | Buy → Buy | |||
05/02/2024 | 127.03% | BTIG | $23 → $21 | Maintains | Buy | |||
05/01/2024 | 94.59% | Benchmark | $18 → $18 | Reiterates | Buy → Buy | |||
05/01/2024 | 116.22% | TD Cowen | $21 → $20 | Maintains | Buy | |||
05/01/2024 | 181.08% | Craig-Hallum | → $26 | Assumes | → Buy | |||
04/30/2024 | 105.41% | Needham | $24 → $19 | Maintains | Buy | |||
02/26/2024 | 116.22% | Piper Sandler | $18 → $20 | Maintains | Overweight | |||
02/22/2024 | 105.41% | Goldman Sachs | $17 → $19 | Maintains | Buy | |||
02/21/2024 | 159.46% | Needham | $21 → $24 | Maintains | Buy | |||
12/29/2023 | 105.41% | TD Cowen | $22 → $19 | Maintains | Outperform | |||
12/29/2023 | 127.03% | BTIG | $25 → $21 | Maintains | Buy | |||
12/28/2023 | 127.03% | Needham | $21 → $21 | Reiterates | Buy → Buy | |||
11/08/2023 | 83.78% | Morgan Stanley | $16 → $17 | Maintains | Equal-Weight | |||
11/07/2023 | 127.03% | Needham | → $21 | Reiterates | Buy → Buy | |||
10/24/2023 | 72.97% | Morgan Stanley | $18 → $16 | Maintains | Equal-Weight | |||
10/23/2023 | 83.78% | Goldman Sachs | $19 → $17 | Maintains | Buy | |||
10/20/2023 | 83.78% | Goldman Sachs | $19 → $17 | Maintains | Buy | |||
10/16/2023 | 94.59% | Piper Sandler | $23 → $18 | Maintains | Overweight | |||
08/21/2023 | 94.59% | Stephens & Co. | $16 → $18 | Upgrade | Equal-Weight → Overweight | |||
08/09/2023 | 94.59% | Benchmark | $20 → $18 | Maintains | Buy | |||
08/09/2023 | 94.59% | Morgan Stanley | $19 → $18 | Maintains | Equal-Weight | |||
08/09/2023 | 127.03% | Needham | → $21 | Reiterates | Buy → Buy | |||
05/16/2023 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
05/10/2023 | 105.41% | Morgan Stanley | $18 → $19 | Maintains | Equal-Weight | |||
05/09/2023 | 170.27% | BTIG | → $25 | Upgrade | Neutral → Buy | |||
05/09/2023 | 137.84% | TD Cowen | $20 → $22 | Maintains | Outperform | |||
05/09/2023 | 127.03% | Needham | → $21 | Reiterates | → Buy | |||
04/18/2023 | 127.03% | Needham | → $21 | Maintains | Buy | |||
04/11/2023 | 83.78% | B of A Securities | $18 → $17 | Maintains | Neutral | |||
04/05/2023 | 127.03% | Needham | → $21 | Reiterates | → Buy | |||
03/03/2023 | 116.22% | Piper Sandler | $18 → $20 | Maintains | Overweight | |||
02/24/2023 | 116.22% | Cowen & Co. | $14 → $20 | Maintains | Outperform | |||
02/24/2023 | 94.59% | Morgan Stanley | $17 → $18 | Maintains | Equal-Weight | |||
02/24/2023 | 116.22% | Benchmark | → $20 | Upgrade | Hold → Buy | |||
02/24/2023 | 105.41% | Raymond James | $12 → $19 | Maintains | Outperform | |||
02/24/2023 | 127.03% | Needham | $15 → $21 | Maintains | Buy | |||
02/01/2023 | 62.16% | Needham | → $15 | Upgrade | Hold → Buy | |||
11/14/2022 | 94.59% | Piper Sandler | $19 → $18 | Maintains | Overweight | |||
11/11/2022 | 29.73% | Raymond James | $15 → $12 | Maintains | Outperform | |||
11/09/2022 | 83.78% | Morgan Stanley | $18 → $17 | Maintains | Equal-Weight | |||
11/09/2022 | 62.16% | SVB Leerink | $12 → $15 | Maintains | Outperform |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de NeoGenomics (NEO)?
El último precio objetivo de NeoGenomics (NASDAQ:NEO) fue comunicado por TD Cowen el septiembre 12, 2025. La firma de analistas fijó un precio objetivo para $12.00 que espera NEO a rise dentro de 12 meses (un posible 29.73% upside). 24 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre NeoGenomics (NEO)?
La última calificación de analistas para NeoGenomics (NASDAQ:NEO) fue proporcionada por TD Cowen, y NeoGenomics mantuvo su buy calificación.
¿Cuándo se produjo la última revisión al alza de NeoGenomics (NEO)?
La última revisión al alza de NeoGenomics Inc se produjo en agosto 21, 2023, cuando Stephens & Co. elevó su precio objetivo a $18. Stephens & Co. anteriormente tenía an equal-weight para NeoGenomics Inc.
¿Cuándo fue la última revisión a la baja de NeoGenomics (NEO)?
La última revisión a la baja de NeoGenomics Inc se produjo en julio 29, 2025, cuando William Blair cambió su precio objetivo de N/A a N/A para NeoGenomics Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para NeoGenomics (NEO)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de NeoGenomics, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de NeoGenomics se registró el septiembre 12, 2025, por lo que la próxima calificación estará disponible en torno al septiembre 12, 2026.
¿Es correcta la calificación de los analistas sobre NeoGenomics (NEO)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de NeoGenomics (NEO) fue un mantuvo con un precio objetivo de $10.00 a $12.00. El precio actual al que cotiza NeoGenomics (NEO) es de $9.25, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.